

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.59%
-1.17%
+0.23%
PCRX
Pacira BioSciences I
$21.82
Chart
$25.34 (-13.89%)
$22.07 (-1.13%)
$26.98 (-19.13%)
$17.7 (+23.28%)
PCRX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

PCRX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
PCRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCRX Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayPCRX Earnings
The TTM reflects 12-month period, providing review of PCRX financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is PCRX current stock price?
What are PCRX stock strengths?
What risks are associated with PCRX stock?
When is PCRX next earnings report?
What is PCRX market cap and volume?
What is PCRX's current Stock IQ?
Should I buy PCRX stock right now?
Is PCRX a Strong Buy right now?
What does a 'Strong Buy' rating mean for PCRX?
What does a 'Strong Sell' rating mean for PCRX?
What factors influence PCRX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.59%
-1.17%
+0.23%
PCRX
Pacira BioSciences I
Current Price
$21.82
Stock Insights
Not Enough Information
Chart
$25.34 (-13.89%)
$22.07 (-1.13%)
$26.98 (-19.13%)
$17.7 (+23.28%)
PCRX Analysts Opinion
PCRX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
PCRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCRX Street view is unimpressive and have negative views on the near-term outlook
PCRX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
PCRX Earnings
The TTM data reflects the most recent 12-month period, providing overview of PCRX financial performance.
PCRX Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
PCRX Latest Analysis
Pacira Stock Slides 6.7% On ANDA Filing Threat To Flagship Drug . (RTTNews) - Pacira BioSciences Inc. (PCRX) dropped 6.69% to $21.48 down $1.54 after receiving a Paragraph IV certification notice from The WhiteOak Group which filed an Abbreviated New Drug Application - ANDA challenging the patents covering Paciras lead product EXPAREL.
Tue Oct 21, 2025
Pacira BioSciences stock falls after generic challenge to EXPAREL.
Tue Oct 21, 2025
Pacira BioSciences Becomes Oversold (PCRX). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Oct 8, 2025
Pacira BioSciences (PCRX) Shares Cross Below 200 DMA. In trading on Monday shares of Pacira BioSciences Inc (Symbol: PCRX) crossed below their 200 day moving average of $24.30 changing hands as low as $24.11 per share. Pacira BioSciences Inc shares are currently trading down about 2.7% on the day. The chart below shows the one
Mon Oct 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PCRX Stock trends
PCRX Stock performance
PCRX Stock analysis
PCRX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.